Sufentanil Citrate (Akorn, Inc.)


Welcome to the PulseAid listing for the Sufentanil Citrate drug offered from Akorn, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Sufentanil Citrate
SUBSTANCE NAME: SUFENTANIL CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
ROUTE: EPIDURAL; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-12-01
END MARKETING DATE: 0000-00-00


Sufentanil Citrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSufentanil Citrate from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE: CII
ACTIVE STRENGTH: 50(ug/mL)
START MARKETING DATE: 2010-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-050_ada2f7c7-1ba9-4216-8496-5df11556392c
PRODUCT NDC: 17478-050
APPLICATION NUMBER: NDA019050

Other SUFENTANIL CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Sufentanil Citrate
Hospira, Inc.Sufentanil Citrate
West-ward Pharmaceutical Corp.Sufentanil Citrate